Grifols, S.A. announced that on 3 January 2014 a $1.5 billion bridge loan has been signed and fully subscribed in equal parts by Nomura, BBVA and Morgan Stanley. The loan will be used for the payment related to the acquisition of the diagnostics business unit of the Swiss company Novartis International AG (Novartis) as informed in the Relevant Event dated 11th November 2013. The loan does not include any financial restrictions with respect to Grifols dividends policy or investments.